| Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway VS Viswanathan, MJ Ryan, HD Dhruv, S Gill, OM Eichhoff, ... Nature 547 (7664), 453-457, 2017 | 1463 | 2017 |
| Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition MJ Hangauer, VS Viswanathan, MJ Ryan, D Bole, JK Eaton, A Matov, ... Nature 551 (7679), 247-250, 2017 | 1275 | 2017 |
| Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles JK Eaton, L Furst, RA Ruberto, D Moosmayer, A Hilpmann, MJ Ryan, ... Nature chemical biology 16 (5), 497-506, 2020 | 291 | 2020 |
| Genomic alteration burden in advanced prostate cancer and therapeutic implications MJ Ryan, R Bose Frontiers in Oncology 9, 1287, 2019 | 31 | 2019 |
| Targeting a therapy-resistant cancer cell state using masked electrophiles as GPX4 inhibitors JK Eaton, L Furst, RA Ruberto, D Moosmayer, RC Hillig, A Hilpmann, ... bioRxiv, 376764, 2018 | 16 | 2018 |
| Modulation of ferroptosis sensitivity by TXNRD1 in pancreatic cancer cells LL Cai, RA Ruberto, MJ Ryan, JK Eaton, SL Schreiber, VS Viswanathan BioRxiv, 2020.06. 25.165647, 2020 | 13 | 2020 |
| Sialidases as regulators of bioengineered cellular surfaces CY Zamora, MJ Ryan, M d'Alarcao, K Kumar Glycobiology 25 (7), 784-791, 2015 | 8 | 2015 |
| Abstract B098: GPX4 is a broadly shared gene vulnerability among residual tumors MJ Hangauer, VS Viswanathan, MJ Ryan, D Bole, JK Eaton, A Matov, ... Molecular Cancer Therapeutics 17 (1_Supplement), B098-B098, 2018 | | 2018 |
